The US Food and Drug Administration (US-FDA) conducted a general cGMP inspection of Divi's Laboratories Limited's Unit-II manufacturing facility at Chippada Village, Bheemunipatnam Mandal, Visakhapatnam, Andhra Pradesh from July 11, 2024 to July 19, 2024.
The US-FDA inspection is successfully completed with one procedural observation, which will be addressed in the stipulated period of time.
Shares of Divi's Laboratories Limited was last trading in BSE at Rs. 4520.10 as compared to the previous close of Rs. 4582.30. The total number of shares traded during the day was 5524 in over 1178 trades.
The stock hit an intraday high of Rs. 4598.95 and intraday low of 4498.80. The net turnover during the day was Rs. 25046022.00. |
